Patent details

EP1246839 Title: DEPSIPEPTIDE AND CONGENERS THEREOF FOR USE AS IMMUNOSUPPRESSANTS

Basic Information

Publication number:
EP1246839
PCT Application Number:
PCT/US/2000/033169
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP009839978
PCT Publication Number:
WO/2001/042282
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DEPSIPEPTIDE AND CONGENERS THEREOF FOR USE AS IMMUNOSUPPRESSANTS
French Title of Invention:
DEPSIPEPTIDE ET SES CONGENERES DESTINES A ETRE UTILISES EN TANT QU'IMMUNODEPRESSEURS
German Title of Invention:
DEPSIPEPTIDE UND DEREN ANALOGE ZUR VERWENDUNG ALS IMMUNOSUPPRESSIVA
SPC Number:

Dates

Filing date:
06/12/2000
Grant date:
16/06/2004
EP Publication Date:
16/06/2004
PCT Publication Date:
14/06/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/10/2002
EP B1 Publication Date:
16/06/2004
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
06/12/2020
Renunciation date:
Revocation date:
06/12/2004
Annulment date:

Owner

From:
07/05/2009
 
 

Name:
Cyclacel Pharmaceuticals Inc.
Address:
1124 Columbia Street, Suite 130, Seatlle, WA 98104-2046, United States (US)

Inventor

Name:
SKOV Soren, The Panum institute
Address:
Denmark (DK)

Priority

1

Priority Number:
169731 P
Priority Date:
08/12/1999
Priority Country:
United States (US)

2

Priority Number:
193582 P
Priority Date:
30/03/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 11/00;
Filing date Document type Number of pages